Results 71 to 80 of about 54,777 (206)

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination

npj Vaccines, 2023
Gardasil® (Merck) and Cervarix® (GlaxoSmithKline) both provide protection against infection with Human Papillomavirus 16 (HPV16) and Human Papillomavirus 18 (HPV18), that account for around 70% of cervical cancers. Both vaccines have been shown to induce
Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger, Galit Alter   +10 more
doaj   +1 more source

The role of Microenvironment in tumorigenesis. Focus on dendritic cells in human papillomavirus E6, E7-transformed keratinocytes [PDF]

, 2015
The inception of tumor microenvironment (TME), a complex and dynamic system constituted by different types of cells engaged by tumor and extracellular matrix surrounding cancer cells, is a way for them to elude the immune surveillance.
Accardi, Rosita, CHIANTORE, Maria Vincenza, Fiorucci, Gianna, IULIANO, MARCO, MANGINO, GIORGIO, ROMEO, Giovanna, Tommasino, Massimo   +6 more
core   +1 more source

Investigating the knowledge and attitude of mothers with teenagers toward human papillomavirus vaccine injection

Journal of Education and Health Promotion
BACKGROUND: Human papillomavirus (HPV) is a large family of viruses and is considered the most common sexually transmitted infection. One of the effective and cost-effective primary prevention methods are vaccines made against the HPV.
Leila Shasti, Sayeda Zeinab Hoseinnezhad, Zohre Keshavarz, Maryam Najiabhary, Farangis Habibi, Zeinab Hamzegardeshi   +5 more
doaj   +1 more source

HPV vaccination of immunocompromised hosts

Papillomavirus Research, 2017
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly ...
S.M. Garland, J.M.L. Brotherton, A.B. Moscicki, A.M. Kaufmann, M. Stanley, N. Bhatla, R. Sankaranarayanan, S. de Sanjosé, J.M. Palefsky   +8 more
doaj   +1 more source

Mandatory HPV Vaccination and Political Debate [PDF]

, 2011
Vaccinations are among the most cost-effective and widely used public health interventions, but have provoked popular resistance, with compulsion framed as an unwarranted state interference.
Gostin, Lawrence O.
core   +2 more sources

Human papillomavirus and vaccination [PDF]

Journal of the American Academy of Dermatology, 2023
Ahmad, Nofal, Al-Shimaa M, Ibrahim, Eman, Nofal, Manal, Nabil, Ayman, Marei   +4 more
openaire   +5 more sources

Human papillomavirus and HPV vaccines: a review

Bulletin of the World Health Organization
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
FT Cutts, S Franceschi, S Goldie, X Castellsague, S de Sanjose, G Garnett, WJ Edmunds, P Claeys, KL Goldenthal, DM Harper, L Markowitz   +10 more
doaj   +1 more source

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. [PDF]

, 2015
IntroductionHIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable populations in the world: women in low- and middle-income countries (LMICs).
Cohen, Craig R, Huchko, Megan J, Maloba, May, Nakalembe, Miriam   +3 more
core   +3 more sources

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [PDF]

, 2019
The manuscript was reviewed by Jo’s Trust, which supports the conclusions. It made the following statement: We think (it has) massive implications for the screening programme, vaccine and also impact on diagnoses in the future.
Cruickshank, Margaret, Cuschieri, Kate, Kavanagh, Kim, Palmer, Tim, Pollock, Kevin G., Robertson, Chris, Wallace, Lynn   +6 more
core   +4 more sources

Therapeutic Human Papillomavirus Vaccination

Public Health Genomics, 2009
Despite impressive progress in prevention and therapy of premalignant and malignant dysplasia the worldwide burden of cancer is relatively unchanged. Supplementation of the therapeutic arsenal by immunotherapeutic methods would have the potential to make a significant impact.
Andreas E, Albers, Andreas M, Kaufmann
openaire   +2 more sources